Annual Total Long Term Liabilities
$33.58 M
+$18.84 M+127.77%
31 December 2023
Summary:
Lyra Therapeutics annual total long term liabilities is currently $33.58 million, with the most recent change of +$18.84 million (+127.77%) on 31 December 2023. During the last 3 years, it has risen by +$32.13 million (+2209.70%). LYRA annual total long term liabilities is now -74.77% below its all-time high of $133.09 million, reached on 31 December 2019.LYRA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$43.18 M
-$1.15 M-2.59%
30 September 2024
Summary:
Lyra Therapeutics quarterly total long term liabilities is currently $43.18 million, with the most recent change of -$1.15 million (-2.59%) on 30 September 2024. Over the past year, it has increased by +$26.08 million (+152.52%). LYRA quarterly long term liabilities is now -73.41% below its all-time high of $162.39 million, reached on 31 March 2020.LYRA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +127.8% | +152.5% |
| 3 y3 years | +2209.7% | +1441.7% |
| 5 y5 years | -74.3% | - |
LYRA Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2209.7% | -4.7% | +3013.4% |
| 5 y | 5 years | -74.8% | +2209.7% | -73.4% | +3510.6% |
| alltime | all time | -74.8% | +2209.7% | -73.4% | +3510.6% |
Lyra Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $43.18 M(-2.6%) |
| June 2024 | - | $44.33 M(-2.1%) |
| Mar 2024 | - | $45.30 M(+34.9%) |
| Dec 2023 | $33.58 M(+127.8%) | $33.58 M(+96.4%) |
| Sept 2023 | - | $17.10 M(+31.7%) |
| June 2023 | - | $12.99 M(-4.7%) |
| Mar 2023 | - | $13.62 M(-7.6%) |
| Dec 2022 | $14.74 M | $14.74 M(+16.7%) |
| Sept 2022 | - | $12.64 M(+38.4%) |
| June 2022 | - | $9.13 M(+558.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.39 M(-39.8%) |
| Dec 2021 | $2.31 M(+58.5%) | $2.31 M(-17.7%) |
| Sept 2021 | - | $2.80 M(-78.3%) |
| June 2021 | - | $12.93 M(+981.0%) |
| Mar 2021 | - | $1.20 M(-17.7%) |
| Dec 2020 | $1.45 M(-98.9%) | $1.45 M(-14.9%) |
| Sept 2020 | - | $1.71 M(-12.8%) |
| June 2020 | - | $1.96 M(-98.8%) |
| Mar 2020 | - | $162.39 M(+22.0%) |
| Dec 2019 | $133.09 M(+2.0%) | $133.09 M |
| Dec 2018 | $130.47 M | - |
FAQ
- What is Lyra Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Lyra Therapeutics?
- What is Lyra Therapeutics annual total long term liabilities year-on-year change?
- What is Lyra Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly long term liabilities year-on-year change?
What is Lyra Therapeutics annual total long term liabilities?
The current annual total long term liabilities of LYRA is $33.58 M
What is the all time high annual total long term liabilities for Lyra Therapeutics?
Lyra Therapeutics all-time high annual total long term liabilities is $133.09 M
What is Lyra Therapeutics annual total long term liabilities year-on-year change?
Over the past year, LYRA annual total long term liabilities has changed by +$18.84 M (+127.77%)
What is Lyra Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of LYRA is $43.18 M
What is the all time high quarterly long term liabilities for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly total long term liabilities is $162.39 M
What is Lyra Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, LYRA quarterly total long term liabilities has changed by +$26.08 M (+152.52%)